JY
FLGT icon

Jeff Yass’s Fulgent Genetics FLGT Stock Holding History

Jeff Yass’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$624K Sell
30,405
-7,673
-20% -$130K ﹤0.01% 9385
2026
Q1 		$605K Buy
38,078
+27,310
+254% +$593K ﹤0.01% 9169
2025
Q4 		$283K Sell
10,768
-9,531
-47% -$247K ﹤0.01% 10082
2025
Q3 		$459K Sell
20,299
-149,666
-88% -$3.08M ﹤0.01% 9164
2025
Q2 		$3.38M Buy
169,965
+108,227
+175% +$2.11M ﹤0.01% 4727
2025
Q1 		$1.04M Buy
61,738
+34,496
+127% +$588K ﹤0.01% 7154
2024
Q4 		$503K Buy
27,242
+12,675
+87% +$247K ﹤0.01% 8645
2024
Q3 		$317K Buy
+14,567
New +$326K ﹤0.01% 9485
2024
Q2 		– Sell
-67,686
Closed -$1.41M – 12372
2024
Q1 		$1.47M Buy
67,686
+52,864
+357% +$1.31M ﹤0.01% 6055
2023
Q4 		$429K Buy
+14,822
New +$397K ﹤0.01% 9046
2023
Q3 		– Sell
-53,975
Closed -$1.84M – 12288
2023
Q2 		$2M Sell
53,975
-35,503
-40% -$1.24M ﹤0.01% 5167
2023
Q1 		$2.79M Buy
89,478
+2,059
+2% +$66.3K ﹤0.01% 4459
2022
Q4 		$2.6M Sell
87,419
-31,630
-27% -$1.13M ﹤0.01% 4242
2022
Q3 		$4.54M Buy
119,049
+62,463
+110% +$3.13M ﹤0.01% 3319
2022
Q2 		$3.09M Buy
56,586
+6,990
+14% +$384K ﹤0.01% 4017
2022
Q1 		$3.1M Sell
49,596
-17,715
-26% -$1.17M ﹤0.01% 4565
2021
Q4 		$6.77M Sell
67,311
-46,951
-41% -$4.13M ﹤0.01% 3254
2021
Q3 		$10.3M Sell
114,262
-50,357
-31% -$4.58M ﹤0.01% 2823
2021
Q2 		$15.2M Buy
164,619
+20,281
+14% +$1.62M ﹤0.01% 2361
2021
Q1 		$13.9M Buy
144,338
+43,484
+43% +$4.49M ﹤0.01% 2323
2020
Q4 		$5.25M Buy
+100,854
New +$4.21M ﹤0.01% 3342
2020
Q2 		– Sell
-98,923
Closed -$1.06M – 10344
2020
Q1 		$1.06M Buy
98,923
+45,800
+86% +$638K ﹤0.01% 5265
2019
Q4 		$685K Buy
+53,123
New +$631K ﹤0.01% 6301
2018
Q4 		– Sell
-25,298
Closed -$99K – 9229
2018
Q3 		$99K Buy
25,298
+5,570
+28% +$23.8K ﹤0.01% 8606
2018
Q2 		$82K Buy
19,728
+8,749
+80% +$34.7K ﹤0.01% 9121
2018
Q1 		$44K Buy
+10,979
New +$48.3K ﹤0.01% 8988

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jeff Yass's FLGT Position: Q2 2026 in Review

Jeff Yass reduced its Fulgent Genetics (FLGT) stake by 20% in Q2 2026, selling an estimated $130K and leaving 30,405 shares worth $624K. The position accounts for ﹤0.01% of the portfolio, ranked #9385.

Jeff Yass first reported a position in FLGT in Q1 2018 and has held it in 26 quarters since. The position peaked at $15.2M in Q2 2021. 141 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Jeff Yass held 30,405 shares of Fulgent Genetics worth $624K as of Q2 2026.
  • Jeff Yass sold 7,673 Fulgent Genetics shares in Q2 2026, an estimated $130K.
  • Fulgent Genetics made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #9385 holding.
  • Jeff Yass first reported a position in Fulgent Genetics in Q1 2018 and has held it in 26 quarters since.
  • Jeff Yass's Fulgent Genetics position peaked at $15.2M in Q2 2021.
  • 141 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.